The global immune thrombocytopenia treatment market is experiencing a period of significant growth. This trend can be attributed to several factors, including an rising prevalence of immune thrombocytopenia worldwide and the release of novel treatment approaches. Additionally, advancements in diagnostic methods are facilitating earlier diagnosis an